6578 Stock Overview
A specialized biotech company, primarily engages in the development of antibiotics alternatives in animal health industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
DaBomb Protein Biotech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$18.90 |
| 52 Week High | NT$33.90 |
| 52 Week Low | NT$18.15 |
| Beta | 0.65 |
| 11 Month Change | -9.13% |
| 3 Month Change | -18.18% |
| 1 Year Change | -0.79% |
| 33 Year Change | 6.78% |
| 5 Year Change | -8.82% |
| Change since IPO | -40.47% |
Recent News & Updates
Shareholder Returns
| 6578 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -2.6% | -4.9% | -4.2% |
| 1Y | -0.8% | -19.2% | 28.9% |
Return vs Industry: 6578 exceeded the TW Personal Products industry which returned -17.8% over the past year.
Return vs Market: 6578 underperformed the TW Market which returned 30.2% over the past year.
Price Volatility
| 6578 volatility | |
|---|---|
| 6578 Average Weekly Movement | 3.7% |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6578 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6578's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Yu Fen Liu | www.dabombprotein.com |
DaBomb Protein Biotech Corp., a specialized biotech company, primarily engages in the development of antibiotics alternatives in animal health industry. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising LACTOTIDES HEALTH A+ and Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its name to DaBomb Protein Biotech Corp. in October 2023.
DaBomb Protein Biotech Corp. Fundamentals Summary
| 6578 fundamental statistics | |
|---|---|
| Market cap | NT$1.24b |
| Earnings (TTM) | NT$7.22m |
| Revenue (TTM) | NT$356.75m |
171.5x
P/E Ratio3.5x
P/S RatioIs 6578 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6578 income statement (TTM) | |
|---|---|
| Revenue | NT$356.75m |
| Cost of Revenue | NT$284.33m |
| Gross Profit | NT$72.42m |
| Other Expenses | NT$65.20m |
| Earnings | NT$7.22m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 20.30% |
| Net Profit Margin | 2.02% |
| Debt/Equity Ratio | 24.8% |
How did 6578 perform over the long term?
See historical performance and comparison